How Zika virus knocks out our immune defenses
LJI and UC San Diego scientists make striking discovery as they work to combat Zika and related viral threats
Disease zika
LJI Professor Sujan Shresta wins new funding to investigate dengue and chikungunya virus vaccines
Shresta and her LJI colleagues work toward pandemic preparedness as members of the national 'ReVAMPP' network
Shresta Lab
Sujan Shresta, Ph.D., and her team study the immunology and virology of mosquito-borne human pathogens such as dengue virus and Zika virus.
Sette Lab
Alessandro Sette, Dr.Biol.Sci., defines in chemical terms the specific structures (epitopes) that the immune system recognizes and uses this knowledge to measure and understand immune responses.
LJI scientists win ‘Prebys Research Heroes’ funding
Prebys Foundation celebrates ground-breaking female researchers
LJI-led team wins top Nucleate honors for virus vaccine development proposal
San Diego scientists work with business experts to advance dengue and Zika virus vaccine strategy
How human cells become Zika virus factories
LJI scientists uncover major clue toward developing a pan-flavivirus therapy
Learning from men. Learning from women.
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
Building true partnerships with overseas labs
As she advances global health, LJI Professor Sujan Shresta takes on three new research projects to support equity for scientists in South and Southeast Asia
Fighting Zika? Call in the T cells
Stopping emerging viruses could depend on getting T cells and antibodies to work together
Fighting mosquito-borne viruses requires a precise balance of immune cells
Future vaccines will need to harness the power of T cells in preventing Zika fever and Japanese encephalitis
